Black Diamond Therapeutics (NASDAQ:BDTX), trading as aPenny Stockat $2.04, fell 2.86% at last closing. The clinical-stage oncology company reported encouraging Phase 2 data for its lead cancer drug and refocused its resources on that program, backed by a cash position extending into 2028. For …
Bionano Genomics (NASDAQ:BNGO), trading as aPenny Stockat $1.22, closed flat at last closing. The maker of optical genome mapping technology grew its revenue and consumables sales in the second quarter and retired its convertible debt, even as it remained a small, lossmaking company. For …
Circle Internet Group (NYSE:CRCL) fell 6.35% to $89.48 at last closing. The issuer of the USDCStablecoingrew its revenue, expanded USDC in circulation and returned to profitability in the second quarter, while advancing its Arc blockchain, even as its shares came under pressure amid a …
Carriage Services (NYSE:CSV) fell 1.60% to $33.11 at last closing. The operator of funeral homes and cemeteries grew its revenue andEarningsin the second quarter as pricing offset a decline in funeral volumes, though concerns about itsDebtweighed on its shares. For investors, the question is …
AutoNation (NYSE:AN) rose 1.41% to $204.08 at last closing. One of the largest U.S. automotive retailers grew its adjustedEarningsfor a sixth consecutive quarter, with a record after-sales gross profit and a scaling captive-finance business, even as new-vehicle volumes softened. For investors, the question is …
The latest US sector performance data for 1 September 2026 shows a mixed but predominantly weak market environment, with Energy (XLE) standing out after gaining 1.27%. Utilities (XLU), Health Care (XLV) and Consumer Staples (XLP) also advanced, while seven sectors declined.
The latest US sector momentum visualization for 1 September 2026 continues to show a rotational structure, with four sectors positioned in Leading, four in Improving, one in Weakening and two in Lagging. Energy, Health Care, Materials and Communication Services remain in the Leading quadrant, …
Vir Biotechnology (NASDAQ:VIR) shares are trading higher, nearing their 52-week high, as investors continue to build on the momentum from strong second-quarter results, which showedEarnings Per Shareof $0.47 against a $0.33 consensus estimate, with revenue up sharply year over year.
Hims & Hers Health (NYSE:HIMS) shares are trading lower, giving back Monday's gain tied to news of the company's Australia expansion, as broader market weakness tied to surging oil prices, a U.S.-Iran conflict escalation, and rising Treasury yields pressures risk assets across sectors.
Kailera Therapeutics (NASDAQ:KLRA) shares are rebounding sharply after tumbling to a fresh 52-week low in the prior session, when the stock fell more than 12% and traded barely above its April IPO price, pressuring its marketCapitalizationto roughly its cash balance. The bounce comes amid …